Showing Form 4 filings for ABBV
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
AbbVie Inc.
Price
$223.65
Shares
18,060
Ownership
392,611
Value/Share
Richard Gonzalez
CEO
Pharmaceuticals
Industry
$228.21
20,333
911,048
Board Director
Dir
$235.69
43,713
139,925
Roberto Zalka
CFO
ABBV
$233.56
5,230
3,197
Purdue David Ryan
SVP, Controller
Unknown
$234.39
18,668
4,619
Siatis Perry C
EVP, GC, SECRETARY
$198.51
13,295
58,247
Donoghoe Nicholas
EVP, CHIEF BUS, STRAT OFFICER
$212.34
17,644
11,577
Reents Scott T
EVP, CFO
$205.45
98,628
388,929
Gonzalez Richard A
$210.45
21,250
6,130
Richmond Timothy J.
EVP, CHRO
$197.90
5,778
22,381